Community respiratory virus infections in immunocompromised patients with cancer.

作者: Estella Whimbey, MD , Janet A. Englund, MD , Robert B. Couch, MD

DOI: 10.1016/S0002-9343(97)80004-6

关键词: VirusRespiratory diseaseImmunologyRespiratory virusRibavirinMedicineViral pneumoniaCoronavirusVirologyPneumoniaViral disease

摘要: Community respiratory viruses, such as syncytial virus (RSV), influenza parainfluenza adenoviruses, and picornaviruses, are an important cause of disease in the immunocompromised adult with cancer. Recent studies have demonstrated that a minimum 31% bone marrow transplant (BMT) recipients 18% adults leukemia who hospitalized acute illness community infection. The temporal occurrence these infections patients tends to mirror their community. clinical illnesses range from self-limited upper fatal pneumonias, depending on type degree immunosuppression. pneumonias may be viral, bacterial/fungal, or mixed. highest frequency progression viral pneumonia has been reported for RSV recently transplanted BMT myelosuppressed leukemia. Studies suggested early therapy combination aerosolized ribavirin intravenous immunoglobulin benefit. Defining effective prophylactic therapeutic strategies will challenge, given diversity wide spectrum varying vulnerability serious disease, frequent presence other opportunistic medical problems. A antiviral drugs immunotherapy need considered potential additive effect well prevent emergence resistant virus, occurs during monotherapy amantadine rimantadine. optimal therapies defined controlled trials; however, it appears favorable response hinge initiation at stage illness.

参考文章(73)
Meyers Jd, Gleaves Ca, Ljungman P, Respiratory virus infection in immunocompromised patients. Bone Marrow Transplantation. ,vol. 4, pp. 35- 40 ,(1989)
Frederick G. Hayden, Carole A. Sable, Orthomyxoviral and paramyxoviral infections in transplant patients. Infectious Disease Clinics of North America. ,vol. 9, pp. 987- 1003 ,(1995) , 10.1016/S0891-5520(20)30712-1
M A Luna, R E Champlin, N Q Mirza, J L Neumann, P A Piedra, R C Morice, J M Goodrich, J A Englund, D Przepiorka, E Whimbey, Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplantation. ,vol. 16, pp. 393- 399 ,(1995)
J D Connor, F G Hayden, J Lane, C A Sable, Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection. Antiviral Therapy. ,vol. 1, pp. 51- 56 ,(1996)
Douay L, Wolf M, Isnard F, Fouillard L, Mouthon L, Bricourt F, Stachowiak J, Lucet Jc, Aoudjhane M, Laporte Jp, Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. Bone Marrow Transplantation. ,vol. 9, pp. 97- 100 ,(1992)
M I Hertz, C H Wendt, Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Seminars in Respiratory Infections. ,vol. 10, pp. 224- 231 ,(1995)
Joseph B. McCormick, Isabel J. King, Patricia A. Webb, Curtis L. Scribner, Robert B. Craven, Karl M. Johnson, Luanne H. Elliott, Rose Belmont-Williams, Lassa Fever New England Journal of Medicine. ,vol. 314, pp. 20- 26 ,(1986) , 10.1056/NEJM198601023140104
Thomas C. Merigan, Robert A. Buchanan, George J. Galasso, Antiviral Agents and Viral Diseases of Man ,(1990)
Bodey Gp, Whimbey E, Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses. Seminars in Respiratory Infections. ,vol. 7, pp. 122- 131 ,(1992)
Scott A Harper, Keiji Fukuda, Timothy M Uyeki, Nancy J Cox, Carolyn B Bridges, None, Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report. ,vol. 55, pp. 1- 40 ,(2004)